The Bactericidal Activity and Spore Inhibition Effect of Manuka Honey against Clostridioides Difficile

Area of Science:

• Microbiology
• Natural Products Chemistry
• Gastroenterology

Background:

• Clostridioides difficile (C. difficile) infection is a significant healthcare challenge, often linked to antibiotic-induced gut microbiome disruption.
• The persistence of C. difficile spores complicates treatment, necessitating novel therapeutic strategies.
• Manuka honey presents an alternative antimicrobial approach due to its unique properties.

Purpose of the Study:

• To evaluate the in vitro antimicrobial and sporicidal activities of manuka honey against C. difficile isolates.
• To determine the impact of different methylglyoxal (MGO) grades on manuka honey's efficacy.
• To assess manuka honey's potential as a treatment for C. difficile infections.

Main Methods:

• Broth microdilution assays were used to determine minimum inhibitory concentrations (MICs) and minimum bactericidal concentrations (MBCs).
• Manuka honeys with MGO grades 30+, 100+, 250+, and 400+ were tested against 20 C. difficile isolates.
• Sporicidal activity was assessed by monitoring total viable cell and spore counts over 96 hours.

Main Results:

• Manuka honey exhibited variable MICs ranging from 4% to >30% (w/v), with MIC50 values between 10-14% across MGO grades.
• MBC results showed a bimodal distribution, indicating inconsistent bactericidal effects.
• While honey inhibited spore proliferation, spore counts remained near baseline, unlike the drug-free control where counts increased significantly.

Conclusions:

• Manuka honey possesses variable inhibitory and bactericidal activity against C. difficile.
• The methylglyoxal (MGO) content of manuka honey did not significantly influence its activity against C. difficile.
• Manuka honey can inhibit C. difficile spore proliferation but does not achieve complete spore eradication.